A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Drug Acquiring Traction Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Worries
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.
Some professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and customer laws, risking penalties, prosecution or prison.
Platform Response and Content Removal
Based on the social media company, the platform has removed violative content and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.
After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.
Product Information and Pricing
Inside these groups, posts display dark colored parcels with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially serious medical dangers”.
